Litcius/Paper detail

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Srikanth Muppidi, Jeffrey T. Guptill, Saiju Jacob, Yingkai Li, Maria Elena Farrugia, Amanda C. Guidon, Jinny Tavee, Henry J. Kaminski, James F. Howard, Gary Cutter, Heinz Wiendl, Matthew B. Maas, Isabel Illa, Renato Mantegazza, Hiroyuki Murai, Kimiaki Utsugisawa, Richard J. Nowak, Amanda C. Guidon, Alok Tyagi, Ana Paula Sousa, Anthony A. Amato, Ashwin Pinto, Bhaskar Roy, Caroline Carmichael, Dubravka Dodig, Georgina Burke, Gary Cutter, Henry J. Kaminski, Heinz Wiendl, Hiroyuki Murai, Ikjae Lee, Isabel Illa, Jeffrey T. Guptill, James F. Howard, James B. Caress, Jane Pritchard, Jinny Tavee, John Vissing, Kamla Best, Kimiaki Utsugisawa, Mahtab Ramezani, Mathew Maas, Maria Elena Farrugia, Michael K. Hehir, Michelle Kaku, Natalia Jiménez Esquivel, Paul R. Gallagher, Paul Maddison, Philip Alexander Ambrose, Renato Mantegazza, Richard J Nowak, Rocio Vazquez Do Campo, Saiju Jacob, Sami Saba, Shahriar Nafissi, Shannon Itoyama, Srikanth Muppidi, Stuart Viegas, Victoria Marshall, Yingkai Li

2020The Lancet Neurology121 citationsDOIOpen Access PDF

Topics & Concepts

Myasthenia gravisMedicineExacerbationPandemicImmunotherapyAzithromycinWeaknessCoronavirus disease 2019 (COVID-19)Intensive care medicineImmunologyInternal medicineDiseaseSurgeryImmune systemInfectious disease (medical specialty)BiologyMicrobiologyAntibioticsMyasthenia Gravis and ThymomaLong-Term Effects of COVID-19
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG) | Litcius